Team:Washington/Gram Negative/Build

From 2010.igem.org

(Difference between revisions)
(Recombineering the type 6 secretion system)
(Building the Tse2/Tsi2 Toxin/ Antitoxin system)
Line 29: Line 29:
=Building the Tse2/Tsi2 Toxin/ Antitoxin system=
=Building the Tse2/Tsi2 Toxin/ Antitoxin system=
 +
The Tse2/Tsi2 locus was amplified using PCR with primers that amplified the region from the start codon of Tse2 to the stop codon of Tsi2.The primers were designed to flank the Tse2/Tsi2 product with approximetly 40bp regions of homology to the psb3k3-F2620 plasmid. The forward primer added 44 basepairs of homology to the 3' end of F2620 to the 5' end of the construct. The reverse primer added 38 basepairs of homology to the suffix end of psB3k3 to the 3' end of the construct. The Tse2/Tsi2 locus was then placed downstream from F2620 via gibson cloning. Gibson cloning is a method that joins regions of homology found on the 5' and 3' ends of linearized molecules( for a more in depth explaination of Gibson cloning, see protocols page).  The end result of this Gibson cloning reaction was a circularized plasmid containing the final F2620-Tse2/Tsi2 construct in psb3k3. The gibson reaction mixture was transformed into electrocompetant Dh5a, and the resulting colonies were miniprepped, and screened for insert of expected length via double restriction digest followed by agarose gel electrophoresis. The minipreps that showed inserts of expected length were sequenced, and it was de4termined that multiple minipreps had F2620-Tse2/Tsi2 inserts with expected sequences.
[[Image:Washington_Building_Tse2_circuit.png|800px|]]
[[Image:Washington_Building_Tse2_circuit.png|800px|]]
 +
=Recombineering the type 6 secretion system=
=Recombineering the type 6 secretion system=
[[Image:Washington_Recombineering_basic.png|800px]]
[[Image:Washington_Recombineering_basic.png|800px]]

Revision as of 06:06, 8 October 2010


Building the Tse2/Tsi2 Toxin/ Antitoxin system

The Tse2/Tsi2 locus was amplified using PCR with primers that amplified the region from the start codon of Tse2 to the stop codon of Tsi2.The primers were designed to flank the Tse2/Tsi2 product with approximetly 40bp regions of homology to the psb3k3-F2620 plasmid. The forward primer added 44 basepairs of homology to the 3' end of F2620 to the 5' end of the construct. The reverse primer added 38 basepairs of homology to the suffix end of psB3k3 to the 3' end of the construct. The Tse2/Tsi2 locus was then placed downstream from F2620 via gibson cloning. Gibson cloning is a method that joins regions of homology found on the 5' and 3' ends of linearized molecules( for a more in depth explaination of Gibson cloning, see protocols page). The end result of this Gibson cloning reaction was a circularized plasmid containing the final F2620-Tse2/Tsi2 construct in psb3k3. The gibson reaction mixture was transformed into electrocompetant Dh5a, and the resulting colonies were miniprepped, and screened for insert of expected length via double restriction digest followed by agarose gel electrophoresis. The minipreps that showed inserts of expected length were sequenced, and it was de4termined that multiple minipreps had F2620-Tse2/Tsi2 inserts with expected sequences. Washington Building Tse2 circuit.png

Recombineering the type 6 secretion system

Washington Recombineering basic.png

Designing the Gram(-) Therapeutic       Testing the Gram(-) Therapeutic